p16INK4a Overexpression Is Not Linked to Oncogenic Human Papillomaviruses in Patients With High-Grade Urothelial Cancer Cells

被引:10
作者
Piaton, Eric [1 ,2 ]
Casalegno, Jean-Sebastien [1 ,3 ]
Advenier, Anne-Sophie [1 ,2 ]
Decaussin-Petrucci, Myriam [1 ,4 ]
Mege-Lechevallier, Florence [1 ,5 ]
Ruffion, Alain [1 ,6 ]
Mekki, Yahia [1 ,3 ]
机构
[1] Univ Lyon 1, F-69365 Lyon, France
[2] Hosp Civils Lyon, Hop Femme Mere Enfant, Ctr Pathol Est, Bron, France
[3] Hosp Civils Lyon, Hop Femme Mere Enfant, Lab Virol, Bron, France
[4] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Ctr Pathol Sud, Pierre Benite, France
[5] Hosp Civils Lyon, Hop Edouard Herriot, Serv Anat & Cytol Pathol, Lyon, France
[6] Ctr Hosp Lyon Sud, Serv Urol, Pierre Benite, France
关键词
p16(INK4a); HPV genotyping; urine; urothelial; bladder cancer; cytology; URINARY-BLADDER; P16; EXPRESSION; INFECTION; CARCINOMA; P53; HPV; P16INK4A; CYTOLOGY; MARKER; HYPERMETHYLATION;
D O I
10.1002/cncy.21462
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUNDp16(INK4a) Is overexpressed in almost all precancerous and carcinomatous lesions of the uterine cervix, secondary to interference between high-risk human papillomaviruses (hr-HPVs) and the retinoblastoma gene product. Overexpression of p16(INK4a) has also been identified in patients with high-grade urothelial lesions, both cytologically and histologically. However, the etiological role of HPV has not been documented except in inverted papillomas, low-grade bladder tumors, and younger patients. We therefore attempted to verify if HPV DNA was detectable in p16(INK4a)-positive urothelial tumors. METHODSA total of 90 urinary cytology samples (33 negative/low-grade cases and 57 high-grade proliferations) were analyzed for p16(INK4a) and HPV DNA. HPV genotyping was performed by polymerase chain reaction using a low-density DNA microarray enabling the detection of 35 HPVs. A reasoned approach combining tissue genotyping and in situ hybridization (ISH) for hr-HPVs was used in patients with urinary HPV. RESULTSLow-risk HPV (HPV-84) and hr-HPVs (HPV-16, -31, and -70) were detected. The prevalence of hr-HPVs in the urine was low: 5 of 82 patients (6.1%) and only 4 of 50 patients (8.0%) with high-grade urothelial malignancy. p16(INK4a) overexpression was noted in 49 high-grade samples (85.9%). In patients with p16(INK4a)-positive tumor cells and hr-HPV in the urine, HPV genotyping and ISH for hr-HPVs were negative in matched tissue sections. CONCLUSIONSOur study shows a low prevalence of hr-HPVs in the urine of patients with high-grade urothelial malignancy. In those, p16(INK4a) overexpression occurs in the absence of demonstrable HPV DNA in the tissue sections, contrary to what is noted in gynecopathology. Cancer (Cancer Cytopathol) 2014;122:760-769. (c) 2014 American Cancer Society. The study shows a low prevalence of oncogenic human papillomaviruses (HPVs) in the urine of patients with high-grade urothelial malignancy. In the tissue sections of tumors, p16(INK4a) overexpression occurs in the absence of demonstrable HPV DNA, contrary to what is noted in gynecopathology.
引用
收藏
页码:760 / 769
页数:10
相关论文
共 49 条
  • [1] Value of p16INK4a in the diagnosis of low-grade urothelial carcinoma of the urinary bladder in urinary cytology
    Alameda, Francesc
    Juanpere, Nuria
    Pijuan, Lara
    Lloveras, Belen
    Gimeno, Javier
    Baro, Teresa
    Salido, Marta
    Serrano, Sergio
    Lloreta, Josep
    [J]. CANCER CYTOPATHOLOGY, 2012, 120 (04) : 276 - 282
  • [2] p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma
    Alexander, Riley E.
    Hu, Yingchuan
    Kum, Jennifer B.
    Montironi, Rodolfo
    Lopez-Beltran, Antonio
    MacLennan, Gregory T.
    Idrees, Muhammad T.
    Emerson, Robert E.
    Ulbright, Thomas M.
    Grignon, David G.
    Eble, John N.
    Cheng, Liang
    [J]. MODERN PATHOLOGY, 2012, 25 (11) : 1526 - 1533
  • [3] [Anonymous], VIROLOGY
  • [4] [Anonymous], 1995, PCR STRATEGIES
  • [5] [Anonymous], J PATHOL
  • [6] [Anonymous], AFIP ATLAS TUMOR PAT
  • [7] [Anonymous], UROL ONCOL
  • [8] [Anonymous], ACTA CYTOL S1
  • [9] PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE
    BOSCH, FX
    MANOS, MM
    MUNOZ, N
    SHERMAN, M
    JANSEN, AM
    PETO, J
    SCHIFFMAN, MH
    MORENO, V
    KURMAN, R
    SHAH, KV
    ALIHONOU, E
    BAYO, S
    MOKHTAR, HC
    CHICAREON, S
    DAUDT, A
    DELOSRIOS, E
    GHADIRIAN, P
    KITINYA, JN
    KOULIBALY, M
    NGELANGEL, C
    TINTORE, LMP
    RIOSDALENZ, JL
    SARJADI
    SCHNEIDER, A
    TAFUR, L
    TEYSSIE, AR
    ROLON, PA
    TORROELLA, M
    TAPIA, AV
    WABINGA, HR
    ZATONSKI, W
    SYLLA, B
    VIZCAINO, P
    MAGNIN, D
    KALDOR, J
    GREER, C
    WHEELER, C
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11): : 796 - 802
  • [10] Human papillomavirus and non-muscle invasive urothelial bladder cancer: Potential relationship from a pilot study
    Cai, Tommaso
    Mazzoli, Sandra
    Meacci, Francesca
    Nesi, Gabriella
    Geppetti, Pierangelo
    Malossini, Gianni
    Bartoletti, Riccardo
    [J]. ONCOLOGY REPORTS, 2011, 25 (02) : 485 - 489